Search Results

Filter
  • 1-10 of  25,600 results for ""Bile Duct Neoplasms""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Intraductal papillary neoplasm of the bile duct: diagnostic value of MRI features in differentiating pathologic subclassifications-type 1 versus type 2.

  • Authors : Jeon SK; Department of Radiology, Seoul National University Hospital and Seoul National University College of Medicine, 101 Daehangno, Jongno-Gu, Seoul, 03080, Korea.; Lee JM

Subjects: Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/methods ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/diagnostic imaging ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/pathology

  • Source: European radiology [Eur Radiol] 2024 Jul; Vol. 34 (7), pp. 4674-4685. Date of Electronic Publication: 2023 Dec 19.Publisher: Springer International Country of Publication: Germany NLM ID: 9114774 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinoma.

  • Authors : Wang P; Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer, Shanghai Municipal Health Commission, Minhang Hospital, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, China.

Subjects: Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/genetics ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/pathology ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/metabolism

  • Source: Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217092. Date of Electronic Publication: 2024 Jun 28.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prognostic factors in patients with intrahepatic cholangiocarcinoma.

  • Authors : Chang YJ; Department of General Surgery, Zhong-Xing Branch, Taipei City Hospital, Taipei, Taiwan.; Department of General Surgery, National Taiwan University Hospital, Taipei, Taiwan.

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/mortality ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/surgery

  • Source: Scientific reports [Sci Rep] 2024 Aug 17; Vol. 14 (1), pp. 19084. Date of Electronic Publication: 2024 Aug 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier.

  • Authors : Song Y; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Boerner T

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/mortality

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3499-3511.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265

Record details

×
Academic Journal

Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions.

  • Authors : Zhang G; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China.; Li J

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/therapy ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/immunology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology

  • Source: Clinical and experimental medicine [Clin Exp Med] 2024 Aug 14; Vol. 24 (1), pp. 193. Date of Electronic Publication: 2024 Aug 14.Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Identification and validation of inflammatory subtypes in intrahepatic cholangiocellular carcinoma.

  • Authors : Gao B; Nankai University School of Medicine, Nankai University, Tianjin, China.; Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China.

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics ; Inflammation*/Inflammation*/Inflammation*/pathology

  • Source: Journal of translational medicine [J Transl Med] 2024 Aug 05; Vol. 22 (1), pp. 730. Date of Electronic Publication: 2024 Aug 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.

  • Authors : Burchard PR; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Ruffolo LI

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/drug therapy ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/drug therapy

  • Source: Hepatology communications [Hepatol Commun] 2024 Aug 05; Vol. 8 (8). Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma.

  • Authors : Mohan A; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States.

Subjects: Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/drug therapy ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics

  • Source: The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. 725-730.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma.

  • Authors : Xu S; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, and Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, People's Republic of China.; Cao L

Subjects: Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology

  • Source: The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. e1061-e1072.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Knockdown of long noncoding RNA AL161431.1 inhibits malignant progression of cholangiocarcinoma.

  • Authors : Bai Z; Department of Radiation Oncology, General Hospital of Ningxia Medical University; Cancer Institute, Ningxia Medical University, Yinchuan 750004, Ningxia, PR China.

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/metabolism

  • Source: Aging [Aging (Albany NY)] 2024 Aug 01; Vol. 16 (15), pp. 11501-11512. Date of Electronic Publication: 2024 Aug 01.Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  25,600 results for ""Bile Duct Neoplasms""